GR861601B - Thiazoles their production and pharmaceutical compositions containing them - Google Patents
Thiazoles their production and pharmaceutical compositions containing themInfo
- Publication number
- GR861601B GR861601B GR861601A GR860101601A GR861601B GR 861601 B GR861601 B GR 861601B GR 861601 A GR861601 A GR 861601A GR 860101601 A GR860101601 A GR 860101601A GR 861601 B GR861601 B GR 861601B
- Authority
- GR
- Greece
- Prior art keywords
- thiazoles
- production
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003557 thiazoles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3522354 | 1985-06-22 | ||
DE3522351 | 1985-06-22 | ||
DE3522353 | 1985-06-22 | ||
DE3605868 | 1986-02-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR861601B true GR861601B (en) | 1986-10-20 |
Family
ID=27433378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR861601A GR861601B (en) | 1985-06-22 | 1986-06-20 | Thiazoles their production and pharmaceutical compositions containing them |
Country Status (17)
Country | Link |
---|---|
US (2) | US4737500A (el) |
AU (1) | AU5894086A (el) |
BE (1) | BE904945A (el) |
CH (1) | CH668426A5 (el) |
DK (1) | DK292986A (el) |
ES (2) | ES8802154A1 (el) |
FI (1) | FI862644A (el) |
FR (1) | FR2587342A1 (el) |
GB (1) | GB2177395B (el) |
GR (1) | GR861601B (el) |
HU (1) | HUT43600A (el) |
IL (1) | IL79178A0 (el) |
IT (1) | IT1203806B (el) |
LU (1) | LU86487A1 (el) |
NL (1) | NL8601494A (el) |
PH (1) | PH23389A (el) |
SE (1) | SE8602723L (el) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
HUT43600A (en) * | 1985-06-22 | 1987-11-30 | Sandoz Ag | Process for production of new thiazole derivatives and medical compound containing those |
MX173362B (es) * | 1987-03-02 | 1994-02-23 | Pfizer | Compuestos de piperazinil heterociclicos y procedimiento para su preparacion |
FR2612187B1 (fr) * | 1987-03-12 | 1989-07-21 | Sanofi Sa | Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant |
US4804751A (en) * | 1987-06-30 | 1989-02-14 | American Home Products Corporation | Polycyclic hydrocarbon succinimides with psychotropic activity |
EP0307141B1 (en) * | 1987-09-10 | 1993-01-13 | MERCK SHARP & DOHME LTD. | Oxazoles and thiazoles for the treatment of senile dementia |
US4883795A (en) * | 1988-01-22 | 1989-11-28 | Pfizer Inc. | Piperazinyl-heterocyclic compounds |
EP0350145A3 (en) * | 1988-04-28 | 1990-07-04 | Yamanouchi Pharmaceutical Co. Ltd. | Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both |
US4935424A (en) * | 1988-05-27 | 1990-06-19 | Warner-Lambert Company | 4 or 5-(substituted piperazinylalkyl)-2-aminothiazoles as antipsychotic agents |
US4957916A (en) * | 1988-08-05 | 1990-09-18 | Janssen Pharmaceutica N.V. | Antipsychotic 3-piperazinylbenzazole derivatives |
US5015740A (en) * | 1988-08-05 | 1991-05-14 | Janssen Pharmaceutica N.V. | Antipsychotic 3-piperazinylbenzazole derivatives |
US5077295A (en) * | 1988-09-16 | 1991-12-31 | Pfizer Inc. | Antipsychoic 4-(4-(3-benzisothiazolyl)-1-piperazinyl)buytl bridged bicycle imides |
US4954503A (en) * | 1989-09-11 | 1990-09-04 | Hoechst-Roussel Pharmaceuticals, Inc. | 3-(1-substituted-4-piperazinyl)-1H-indazoles |
US5194436A (en) * | 1991-01-10 | 1993-03-16 | Hoechst-Roussel Pharmaceuticals Inc. | 1-piperazinyl-2-butenes and -2-butynes |
US5130315A (en) * | 1991-01-10 | 1992-07-14 | Raymond R. Wittekind | 1-piperazinyl-2-butenes and -2-butynes |
IT1251144B (it) * | 1991-07-30 | 1995-05-04 | Boehringer Ingelheim Italia | Derivati del benzimidazolone |
SK282231B6 (sk) | 1993-11-19 | 2001-12-03 | Janssen Pharmaceutica N. V. | Farmaceutický prostriedok na liečenie psychotických porúch |
US5889010A (en) * | 1995-05-18 | 1999-03-30 | Pfizer Inc. | Benzimidazole derivatives having dopaminergic activity |
DE19746612A1 (de) | 1997-10-22 | 1999-04-29 | Basf Ag | 2-Substituierte 1,2-Benzisothiazol-Derivate, ihre Herstellung und Verwendung |
US7183410B2 (en) * | 2001-08-02 | 2007-02-27 | Bidachem S.P.A. | Stable polymorph of flibanserin |
US20030060475A1 (en) * | 2001-08-10 | 2003-03-27 | Boehringer Ingelheim Pharma Kg | Method of using flibanserin for neuroprotection |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
BRPI0510074A (pt) * | 2004-04-22 | 2007-10-16 | Boehringer Ingelheim Int | composições farmacêuticas para o tratamento de distúrbios sexuais ii |
US20050239798A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the treatment of premenstrual and other female sexual disorders |
US20060025420A1 (en) * | 2004-07-30 | 2006-02-02 | Boehringer Ingelheimn International GmbH | Pharmaceutical compositions for the treatment of female sexual disorders |
WO2006024471A1 (en) * | 2004-09-03 | 2006-03-09 | Boehringer Ingelheim International Gmbh | Method for the treatment of attention deficit hyperactivity disorder |
CA2599721A1 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of depression |
WO2006096439A2 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases |
WO2006096434A2 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders |
WO2006119884A2 (en) * | 2005-05-06 | 2006-11-16 | Boehringer Ingelheim International Gmbh | Method for the treatment of drug abuse with flibanserin |
JP2008540673A (ja) * | 2005-05-19 | 2008-11-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 薬剤誘発性性機能不全の治療方法 |
ES2646326T3 (es) | 2005-08-03 | 2017-12-13 | Sprout Pharmaceuticals, Inc. | Uso de flibanserina en el tratamiento de la obesidad |
CA2626134C (en) | 2005-10-29 | 2013-12-24 | Boehringer Ingelheim International Gmbh | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
US20070123540A1 (en) * | 2005-10-29 | 2007-05-31 | Angelo Ceci | Sexual desire enhancing medicaments comprising benzimidazolone derivatives |
US20070105869A1 (en) * | 2005-11-08 | 2007-05-10 | Stephane Pollentier | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders |
JP2009536176A (ja) * | 2006-05-09 | 2009-10-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 閉経後の性的欲求障害の治療のためのフリバンセリンの使用 |
DE602007004615D1 (de) | 2006-06-30 | 2010-03-18 | Boehringer Ingelheim Pharma | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen |
WO2008006838A1 (en) * | 2006-07-14 | 2008-01-17 | Boehringer Ingelheim International Gmbh | Use of flibanserin for the treatment of sexual disorders in females |
AR062320A1 (es) | 2006-08-14 | 2008-10-29 | Boehringer Ingelheim Int | Formulaciones de flibanserina y metodo para fabricarlas |
CL2007002214A1 (es) | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp |
EA200900270A1 (ru) | 2006-08-25 | 2009-08-28 | Бёрингер Ингельхайм Интернациональ Гмбх | Системы регулируемого высвобождения и способ их приготовления |
PT2159226T (pt) * | 2007-03-29 | 2016-12-16 | Joint-Stock Company Obninsk Chemical Pharmaceutical Company | Agente anti-histamínico e antialérgico e um método para a produção do mesmo |
CL2008002693A1 (es) | 2007-09-12 | 2009-10-16 | Boehringer Ingelheim Int | Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad |
CA2686480A1 (en) | 2008-12-15 | 2010-06-15 | Boehringer Ingelheim International Gmbh | New salts |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL297170A (el) * | 1963-04-04 | 1900-01-01 | ||
DE1595923A1 (de) * | 1965-02-20 | 1969-11-27 | Merck Ag E | 1-Aralkyl-4-(thiazolyl-2)-piperazine und Verfahren zu ihrer Herstellung |
BE759371A (fr) * | 1969-11-24 | 1971-05-24 | Bristol Myers Co | Azaspirodecanediones heterocycliques et procedes pour leur preparation |
JPS5246935B1 (el) * | 1971-04-06 | 1977-11-29 | ||
BE787059A (fr) * | 1971-08-03 | 1973-02-01 | Wander Ag Dr A | Nouveaux derives du thiazole, leur preparation et leur application comme medicaments |
CH583232A5 (el) * | 1973-02-02 | 1976-12-31 | Wander Ag Dr A | |
US4182763A (en) * | 1978-05-22 | 1980-01-08 | Mead Johnson & Company | Buspirone anti-anxiety method |
US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
DE3321969A1 (de) * | 1983-06-18 | 1984-12-20 | Troponwerke GmbH & Co KG, 5000 Köln | 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
HUT43600A (en) * | 1985-06-22 | 1987-11-30 | Sandoz Ag | Process for production of new thiazole derivatives and medical compound containing those |
-
1986
- 1986-06-09 HU HU862433A patent/HUT43600A/hu unknown
- 1986-06-09 NL NL8601494A patent/NL8601494A/nl not_active Application Discontinuation
- 1986-06-12 CH CH2373/86A patent/CH668426A5/de not_active IP Right Cessation
- 1986-06-18 BE BE1/011508A patent/BE904945A/fr not_active IP Right Cessation
- 1986-06-18 FR FR8608893A patent/FR2587342A1/fr active Pending
- 1986-06-18 SE SE8602723A patent/SE8602723L/xx not_active Application Discontinuation
- 1986-06-19 FI FI862644A patent/FI862644A/fi not_active IP Right Cessation
- 1986-06-19 GB GB8614974A patent/GB2177395B/en not_active Expired
- 1986-06-20 IT IT48157/86A patent/IT1203806B/it active
- 1986-06-20 GR GR861601A patent/GR861601B/el unknown
- 1986-06-20 AU AU58940/86A patent/AU5894086A/en not_active Abandoned
- 1986-06-20 DK DK292986A patent/DK292986A/da not_active Application Discontinuation
- 1986-06-20 IL IL79178A patent/IL79178A0/xx unknown
- 1986-06-20 ES ES556363A patent/ES8802154A1/es not_active Expired
- 1986-06-20 US US06/876,617 patent/US4737500A/en not_active Expired - Fee Related
- 1986-06-20 LU LU86487A patent/LU86487A1/fr unknown
- 1986-06-20 PH PH33910A patent/PH23389A/en unknown
-
1987
- 1987-09-15 ES ES557723A patent/ES8802045A1/es not_active Expired
-
1988
- 1988-02-02 US US07/151,349 patent/US4892879A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FR2587342A1 (fr) | 1987-03-20 |
US4737500A (en) | 1988-04-12 |
ES8802045A1 (es) | 1988-03-16 |
SE8602723L (sv) | 1986-12-23 |
DK292986A (da) | 1986-12-23 |
NL8601494A (nl) | 1987-01-16 |
SE8602723D0 (sv) | 1986-06-18 |
IL79178A0 (en) | 1986-09-30 |
FI862644A0 (fi) | 1986-06-19 |
US4892879A (en) | 1990-01-09 |
GB2177395A (en) | 1987-01-21 |
GB2177395B (en) | 1989-04-26 |
GB8614974D0 (en) | 1986-07-23 |
IT8648157A0 (it) | 1986-06-20 |
HUT43600A (en) | 1987-11-30 |
PH23389A (en) | 1989-07-26 |
ES8802154A1 (es) | 1988-04-01 |
IT1203806B (it) | 1989-02-23 |
ES556363A0 (es) | 1988-04-01 |
CH668426A5 (de) | 1988-12-30 |
FI862644A (fi) | 1986-12-23 |
LU86487A1 (fr) | 1987-01-13 |
AU5894086A (en) | 1986-12-24 |
DK292986D0 (da) | 1986-06-20 |
BE904945A (fr) | 1986-12-18 |
ES557723A0 (es) | 1988-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR861601B (en) | Thiazoles their production and pharmaceutical compositions containing them | |
IL74758A (en) | Acyltripeptides and pharmaceutical compositions containing them | |
NZ216793A (en) | Phenethanolaminotetraline derivatives and pharmaceutical compositions | |
GB8524001D0 (en) | Pharmaceutical composition | |
GB8602787D0 (en) | Pharmaceutical composition | |
GB8602788D0 (en) | Pharmaceutical composition | |
NZ216678A (en) | Heterocyclic substituted-phenoxyalkyl-isoxazoles and -furans and pharmaceutical compositions | |
IL74865A0 (en) | 9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them | |
IL78980A0 (en) | Nasal pharmaceutical compositions and their production | |
GB8530796D0 (en) | Pharmaceutical composition | |
IL79376A (en) | Substituted di-t-butylphenols and pharmaceutical compositions containing them | |
IL76188A (en) | 3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them | |
NZ214821A (en) | Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions | |
NZ217078A (en) | N-piperidyl-benzamide derivatives and pharmaceutical compositions | |
IL86711A0 (en) | 5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them | |
NZ225466A (en) | 1-aminoalkyl-1h-indole derivatives and pharmaceutical compositions containing certain derivatives thereof | |
GB2167414B (en) | Flavolignan derivatives and pharmaceutical compositions containing them | |
NZ215070A (en) | Imidazole-indoles and pharmaceutical compositions | |
NZ216720A (en) | Diazinylpiperidine derivatives and pharmaceutical compositions | |
GR870093B (en) | 8a- acylaminoergolines their production and pharmaceutical compositions containing them | |
IL79003A0 (en) | Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them | |
NZ216438A (en) | Steroid-pyrazoles and pharmaceutical compositions | |
NZ214815A (en) | 12-aminopyridazinopyrroloisoquinoline derivatives and pharmaceutical compositions | |
IL74667A (en) | Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them | |
IL79377A0 (en) | Substituted di-t-butylphenols and pharmaceutical compositions containing them |